Zhangzhou Pientzehuang Pharmaceutical Co Ltd (600436) — Financial Flexibility Index
Zhangzhou Pientzehuang Pharmaceutical Co Ltd (600436) has a Financial Flexibility Index of 0.07x as of September 2025. Free cash flow of CN¥174.25 Million (operating CF CN¥117.38 Million minus capex CN¥56.87 Million) represents 0% of total liabilities (CN¥2.44 Billion). Also explore Zhangzhou Pientzehuang Pharmaceutical Co equity growth rate to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Financial Flexibility Index (2001–2025)
Historical Financial Flexibility Index trend for Zhangzhou Pientzehuang Pharmaceutical Co Ltd across 25 annual periods. Check Zhangzhou Pientzehuang Pharmaceutical Co (600436) strategic asset index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Zhangzhou Pientzehuang Pharmaceutical Co Ltd (2001–2025)
Year-by-year free cash flow to debt coverage for Zhangzhou Pientzehuang Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see 600436 market cap overview.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.17x | CN¥416.82 Million | CN¥77.03 Million | CN¥2.47 Billion | ▼ -80.9% |
| 2024 | 0.88x | CN¥2.38 Billion | CN¥1.31 Billion | CN¥2.70 Billion | ▲ +18.7% |
| 2023 | 0.74x | CN¥2.35 Billion | CN¥2.21 Billion | CN¥3.16 Billion | ▼ -70.7% |
| 2022 | 2.54x | CN¥7.05 Billion | CN¥6.87 Billion | CN¥2.78 Billion | ▲ +978.6% |
| 2021 | 0.24x | CN¥554.44 Million | CN¥462.27 Million | CN¥2.36 Billion | ▼ -75.7% |
| 2020 | 0.97x | CN¥1.89 Billion | CN¥1.47 Billion | CN¥1.95 Billion | ▲ +318.9% |
| 2019 | -0.44x | CN¥-813.94 Million | CN¥-879.37 Million | CN¥1.84 Billion | ▼ -186.9% |
| 2018 | 0.51x | CN¥686.55 Million | CN¥612.31 Million | CN¥1.35 Billion | ▼ -14.7% |
| 2017 | 0.60x | CN¥728.80 Million | CN¥676.93 Million | CN¥1.22 Billion | ▲ +58.0% |
| 2016 | 0.38x | CN¥485.51 Million | CN¥394.54 Million | CN¥1.29 Billion | ▼ -26.2% |
| 2015 | 0.51x | CN¥384.37 Million | CN¥305.51 Million | CN¥751.60 Million | ▲ +16.7% |
| 2014 | 0.44x | CN¥290.36 Million | CN¥264.50 Million | CN¥662.34 Million | ▼ -30.5% |
| 2013 | 0.63x | CN¥420.88 Million | CN¥274.34 Million | CN¥667.05 Million | ▲ +34.1% |
| 2012 | 0.47x | CN¥317.62 Million | CN¥162.40 Million | CN¥675.22 Million | ▼ -33.5% |
| 2011 | 0.71x | CN¥268.51 Million | CN¥232.95 Million | CN¥379.69 Million | ▲ +5.1% |
| 2010 | 0.67x | CN¥244.31 Million | CN¥205.41 Million | CN¥362.97 Million | ▲ +80.7% |
| 2009 | 0.37x | CN¥159.19 Million | CN¥129.52 Million | CN¥427.35 Million | ▲ +66.9% |
| 2008 | 0.22x | CN¥71.08 Million | CN¥12.57 Million | CN¥318.45 Million | ▼ -71.6% |
| 2007 | 0.79x | CN¥166.50 Million | CN¥60.04 Million | CN¥212.03 Million | ▲ +44.8% |
| 2006 | 0.54x | CN¥59.41 Million | CN¥50.70 Million | CN¥109.53 Million | ▼ -55.2% |
| 2005 | 1.21x | CN¥103.59 Million | CN¥69.06 Million | CN¥85.56 Million | ▼ -78.2% |
| 2004 | 5.56x | CN¥109.42 Million | CN¥98.67 Million | CN¥19.69 Million | ▲ +380.1% |
| 2003 | 1.16x | CN¥47.92 Million | CN¥32.36 Million | CN¥41.40 Million | ▲ +71.8% |
| 2002 | 0.67x | CN¥115.22 Million | CN¥105.45 Million | CN¥170.99 Million | ▲ +8.1% |
| 2001 | 0.62x | CN¥77.49 Million | CN¥65.84 Million | CN¥124.34 Million | — |